Aurinia Pharmaceuticals AUPH

NASDAQ AUPH

$16.08 -0.04 (-0.25%)

As of: Sep 4, 2026 · 3:59 PM EDT

Aurinia Pharmaceuticals (AUPH) Restructuring Costs (2024 - 2025)

Analysis

Aurinia Pharmaceuticals (AUPH) Restructuring Costs (2024 - 2025) Analysis & Trends

Peer Set

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	138.47 Bn	130.62 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	85.18 Bn	77.19 Bn	3.93 Bn
3	Argenx Se	63.38 Bn	58.19 Bn	1.37 Bn
4	Moderna	58.09 Bn	52.95 Bn	52.00 Mn
5	Revolution Medicines	44.33 Bn	44.33 Bn	-
6	BeOne Medicines	40.02 Bn	34.92 Bn	1.53 Bn
7	Alnylam Pharmaceuticals	35.57 Bn	32.27 Bn	992.69 Mn
8	Royalty Pharma	28.45 Bn	27.61 Bn	-
9	Insmed	27.48 Bn	26.32 Bn	358.27 Mn
10	Aurinia Pharmaceuticals	2.10 Bn	1.66 Bn	76.67 Mn

Historic Data

Historic Data

Download Data

Date	Value
Jun 30, 2025	114,000.00
Mar 31, 2025	1.53 Mn
Dec 31, 2024	15.35 Mn
Jun 30, 2024	1.07 Mn
Mar 31, 2024	6.68 Mn

Aurinia Pharmaceuticals

NASDAQ: AUPH

$16.08 ▼ -0.04 (-0.25%)

Sep 4, 2026 · 3:59 PM EDT